Our Team

Amanda earned a BS in Environmental Biology from the SUNY College of Environmental Science and Forestry, where she cultivated an interest in the influence of biological, environmental, and lifestyle factors on human disease risk. As an undergraduate student, she examined how differential gene expression in two morphological variants of B. burgdorferi, the causative agent of Lyme disease, contributes to the bacterium’s life strategy. After graduating, Amanda joined Dr. Mahmood Hussain’s laboratory at NYU Long Island School of Medicine’s Diabetes and Obesity Research Center. While there, she explored strategies to prevent and reduce atherosclerosis by investigating miRNAs as potential therapeutic agents and assessing the impact of dietary challenge on plasma lipids and protein activity in transgenic mice. She then transitioned to a clinical research role at Dartmouth Hitchcock Medical Center, where she helped coordinate a Clinical Trials Network (CTN) study that evaluates patient engagement in formal opioid use disorder (OUD) treatment after receiving sublingual or extended-release buprenorphine within the emergency department.

Amanda joined the Center for Technology and Behavioral Health as a research coordinator for a CTN study that aims to optimize methods of retention, duration, and discontinuation of medication for OUD. She hopes to help empower her community with evidence-based methods that help reestablish patient autonomy and improve quality of life. During her leisure time, Amanda enjoys attending concerts and snowboarding.